US 11591381
Gene-edited natural killer cells
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11591381 (Gene-edited natural killer cells) held by CRISPR THERAPEUTICS AG expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K40/15